2.60
+0.1156(+4.66%)
Currency In
| Previous Close | 2.48 |
| Open | 2.45 |
| Day High | 2.68 |
| Day Low | 2.39 |
| 52-Week High | 3.89 |
| 52-Week Low | 2.05 |
| Volume | 21,142 |
| Average Volume | 29,350 |
| Market Cap | 18.12M |
| PE | -6.49 |
| EPS | -0.4 |
| Moving Average 50 Days | 2.71 |
| Moving Average 200 Days | 2.92 |
| Change | 0.12 |
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
GlobeNewswire Inc.
Jan 21, 2025 6:45 PM GMT
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children a
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
GlobeNewswire Inc.
Jan 21, 2025 2:00 PM GMT
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children a
NeurAxis Inc. Issues Letter to Shareholders
GlobeNewswire Inc.
Jan 13, 2025 2:00 PM GMT
CARMEL, Ind., Jan. 13, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children a